首页> 外国专利> human anti-vegfr2 antibody for antiangiogenic and targeted cancer therapy

human anti-vegfr2 antibody for antiangiogenic and targeted cancer therapy

机译:人类抗vegfr2抗体用于抗血管生成和靶向癌症治疗

摘要

The present invention relates to an isolated antibody or antigen binding fragment thereof having a specific binding affinity for an epitope located within the domain 1 or domain 3 of the human vascular endothelial growth factor receptor 2 (vegfr2; seq. id: 74). the epitope within domain 3 of vegfr2 is located between amino acid residues 250 and 270 of sequence: 74. the use of the antibody or antigen-binding fragment thereof in the manufacture of a medicament to inhibit tumor development, The angiogenesis of the tumor, and / or to induce cytotoxicity of cancer cells in an individual in need thereof is also described. A method of detecting the presence of vegfr2 in a vascular tumor endothelial cell or a cancer cell in a biological sample is also described.
机译:本发明涉及对位于人血管内皮生长因子受体2的域1或域3(vegfr2; seq.id:74)中的表位具有特异性结合亲和力的分离的抗体或其抗原结合片段。 vegfr2结构域3内的表位位于序列的氨基酸残基250和270之间:74.抗体或其抗原结合片段在制备抑制肿瘤发展的药物,肿瘤的血管生成和也描述了在有需要的个体中诱导癌细胞的细胞毒性。还描述了检测生物样品中的血管肿瘤内皮细胞或癌细胞中vegfr2的存在的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号